| 1 |
Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency[J]. Front Immunol, 2014, 22(5):162.
|
| 2 |
Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes[J]. Br J Haematol, 2010, 149(1):167-180.
|
| 3 |
Niemela JE, Lu L, Fleisher TA, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis [J]. Blood, 2011, 117(10):2883-2886.
|
| 4 |
Kirkpatrick P1, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand[J]. J Clin Immunol, 2007, 27(5):517-524.
|
| 5 |
Stray-Pedersen A, Abrahamsen TG, FrØland SS. Primary immunodeficiency diseases in Norway [J]. J Clin Immunol, 2000, 20(6):477-485.
|
| 6 |
Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States[J]. J Clin Immunol, 2007, 27(5):497-502.
|
| 7 |
CEREDIH. The French PID study group. The French national registry of primary immunodeficiency diseases [J]. Clin Immunol, 2010, 135(2):264-272.
|
| 8 |
Subbarayan A, Colarusso G, Hughes SM, et al. Clinical features that identify children with primary immunodeficiency diseases[J]. Pediatrics, 2011, 127(5):810-816.
|
| 9 |
Salzer U, Warnatz K, Peter HH, et al. Common variable immunodeficiency:an update[J]. Arthritis Res Ther, 2012, 14(5):223.
|
| 10 |
Lee PP, Lau YL. Primary immunodeficiencies: "new" disease in an old country[J]. Cell Mol Immunol, 2009, 6(6):397-406.
|
| 11 |
Modell V, Gee B, Lewis DB, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation[J]. Immunol Res, 2011, 51(1):61-70.
|
| 12 |
Rezaei N, Mahmoudi E, Aghamohammadi A, et al. X-linked lymphoproliferativesyndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma [J]. Br J Haematol, 2011, 152(1):13-30.
|
| 13 |
Veillette A, Pérez-Quintero LA, Latour S, et al. X-linked lymphoproliferative syndromes and related autosomal recessive disorders[J]. Curr Opin Allergy Clin Immunol, 2013, 13(6):614-622.
|
| 14 |
Booth C, Gilmour KC, Veys P, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease [J]. Blood, 2011, 117(1):53-62.
|
| 15 |
Watzl C, Claus M. WhatSAP-2B4 sends mixed messages in the absence of SAP[J]. Eur J Immunol, 2014, 44(5):1281-1284.
|
| 16 |
Waggoner SN, Kumar V. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection [J]. Front Immunol, 2012, 11(3):377.
|
| 17 |
Sankararaman S, Riel-Romero RM, Jeroudi M, et al. Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferativedisease [J]. J Neurosci Rural Pract, 2014, 5(2):171-174.
|
| 18 |
Sandlund JT, Shurtleff SA, Onciu M, et al. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms [J]. Pediatr Blood Cancer, 2013, 60(9):E85-E87.
|
| 19 |
Huck K, Feyen O, Niehues T, et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation[J]. J Clin Invest, 2009, 119(5):1350-1358.
|
| 20 |
Stepensky P, Weintraub M, Yanir A, et al. IL-2-inducible T cell kinase deficiency: clinical presentation and therapeutic approach [J]. Hematologica, 2011, 96(3):472-476.
|
| 21 |
Prince AL, Yin CC, Enos ME, et al. The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development [J]. Immunol Rev, 2009, 228(1):115-131.
|
| 22 |
Atherly LO, Brehm MA, Welsh RM, et al. Tec kinases Itk and Rlk are required for CD81 T cell responses to virus infection independent of their role in CD41 T cell help[J]. J Immunol, 2006, 176:1571-1581.
|
| 23 |
Li FY, Chaigne-Delalande B, Su H, et al. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus[J]. Blood, 2014, 123(14):2148-2152.
|
| 24 |
Minegishi Y. Hyper-IgE syndrome[J]. Curr Opin Immunol, 2009, 21(5):487-492.
|
| 25 |
Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations[J]. N Engl J Med, 2009, 361(21):2046-2055.
|
| 26 |
Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome [J]. J Allergy Clin Immunol, 2009, 124(6):1289-1302, e4.
|
| 27 |
Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity [J]. Immunity, 2006, 25(5):745-755.
|
| 28 |
Ruusala A, Aspenstrom P. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology [J]. FEBS Lett, 2004, 572(1-3):159-166.
|
| 29 |
Al Khatib S, Keles S, Garcia-Lloret M, et al. Defects along the T (H) 17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome[J]. J Allergy Clin Immunol, 2009, 124(2):342-348, e1-e5.
|
| 30 |
Mizesko MC, Banerjee PP, Monaco-Shawver L, et al. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency [J]. J Allergy Clin Immunol, 2013, 131(3):840-848.
|
| 31 |
Randall KL, Lambe T, Johnson A, et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production[J]. Nat Immunol, 2009, 10(12):1283-1291.
|
| 32 |
Takahashi K, Kohno T, Ajima R, et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer [J]. Int J Oncol, 2006, 28(2):321-328.
|
| 33 |
Saelee P, Wongkham S, Puapairoj A, et al. Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma [J]. Asian Pac J Cancer Prev, 2009, 10(3):501-506.
|
| 34 |
Lane J, Martin T, Weeks HP, et al. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer [J]. Cancer Genomics Proteomics, 2014, 11(3):155-165.
|
| 35 |
Thrasher A J, Burns SO. Wasp: a key immunological multitasker [J]. Nat Rev Immunol, 2010, 10(3):182-192.
|
| 36 |
Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review[J]. Ann NY Acad Sci, 2013, 1285:26-43.
|
| 37 |
Lang PA, Shaabani N, Borkens S, et al. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency[J]. J Allergy Clin Immunol, 2013, 131(3):815-824.
|
| 38 |
Shimizu M, Kanegane H, Wada T, et al. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia[J]. J Allergy Clin Immunol, 2013, 131(2):587-590.
|